Startup compensation is an opaque and awkward topic for first-time academic founders.🤔
How much equity do I receive? My CEO? The PI(s)? Other co-founders? How will my choices affect future compensation?
Check out our latest analysis 👇
https://t.co/w2JuRUISd3
#startupequity
We’ve extended our submission deadline for #Science2Startup 2025 on May 14.
This is your last chance to share your game-changing #startup idea with top #biotech and #pharma execs, VCs, and entrepreneurs — apply now!
Applications are due on Dec 2: https://t.co/djarZfvuHK
Time is running out! #Science2Startup 2025, on May 14, provides research applicants the chance to receive mentorship from #biotech and #pharma leaders.
Submit your application by November 15, to pitch your innovative #startup ideas to industry experts: https://t.co/djarZfuWSc
The 2024 #Science2Startup symposium is tomorrow!
After exciting discussions and powerful networking, 8 researchers will present their ideas and interact with leading investors and executives in the Boston #biotech hub.
Make sure to follow along for updates!
Thank you to #Science2Startup sponsor @Deloitte for hosting this year's academic workshop, Considerations for setting up your finance organization during company scaling.”
To learn more about the event, please visit: https://t.co/haN5VmB6p8
#biotech#pharma#startup
We are delighted to share the #Science2Startup class of 2024!
This year’s 8 scientific presenters were selected by an advisory group of experienced #biotech investors to present their #startup ideas on April 10th at the @broadinstitute.
Learn more: https://t.co/haN5VmB6p8
We're excited to share today's #Science2Startup presenter spotlight: @AriellaShikanov, Ph.D.
Shikanov’s presentation will focus on: “Restoring Natural Ovarian Endocrine Function for Pediatric Cancer Survivors”
Follow along for updates!
@UMengineering@ShikanovLab
We're excited to share today's #Science2Startup presenter spotlight: Rivka Dikstein, Ph.D.
Dikstein’s presentation will focus on: “Spt5-Pol II Inhibitors as an Effective Therapeutic Approach for Huntington's Disease”
Follow along for updates!
@WeizmannScience
We are thrilled to welcome @davidrliu, Ph.D. to lead our fireside chat at #Science2Startup on April 10th at the @broadinstitute: https://t.co/haN5VmBEeG
Liu is a renowned business leader who has successfully launched, led, and scaled #healthcare companies and products.
We’re excited to host #Science2Startup where 8 presenters from leading global academic institutions will present their startup ideas to #biotech investors and executives.
Learn more about the symposium here: https://t.co/haN5VmB6p8
Head of AbbVie Ventures, Christian R. Schubert, Ph.D. will join researchers, entrepreneurs, and top investors this April for the 2024 #Science2Startup symposium!
Learn more about the event and the how it is supporting the future of #biotech: https://t.co/haN5VmB6p8
.@tpg's Partner and Managing Director's, Shinichiro Fuse, Ph.D. will join researchers, entrepreneurs, and top investors this April for the 2024 #Science2Startup symposium!
Learn more about the event and the how it is supporting the future of #biotech: https://t.co/haN5VmB6p8
We’re excited to collaborate with our amazing partners to host this year’s #Science2Startup, a symposium where the top execs, VCs, and entrepreneurs will gather in Boston to bring #biotech startup ideas to life.
Read the announcement: https://t.co/gMkKZPSTet
@OUP_VC's Matt Cohen, Ph.D. will join researchers, entrepreneurs, and top investors this April for the 2024 #Science2Startup symposium!
Learn more about the event and the how it is supporting the future of #biotech: https://t.co/haN5VmB6p8
🤔 Are you curious about how the venture market is currently trending the startup space?
If so, join OUP for our annual discussion that outlines trends in the 🧬 life sciences and the tech🔋and physical sciences🖥
📆 03.14.24 | 🕛 12:00pm ET | 📝 https://t.co/CHbBLndroF
“I think the future of genetic medicine is going to depend on optimizing both delivery, as well as the cargo side of the equation.” -- Shehnaaz Suliman, CEO of Recode Therapeutics
Read more here: https://t.co/qMJ0BQRp0F
DEADLINE APPROACHING - #Science2Startup 2024 will be on April 10th. The one-day symposium is a unique opportunity for researchers to receive guidance and mentorship from leaders in the biotech space. Applications are due October 30th - Submit here: https://t.co/haN5VmB6p8